DreamLab users help accelerate cancer research Play
Media Community

Vodafone urges Kiwis to say goodnight to cancer with DreamLab App

Media Release - With one in three Kiwis affected by cancer in their lifetime, Vodafone and the Vodafone Foundation have teamed up to launch an innovative app which harnesses the processing power of your smartphone to speed up cancer research.

Revolutionary research has begun to understand cancer based on a patient’s DNA profile, but hampering the speed of that genetic profiling is the lack of access to computer processing power.

The Vodafone DreamLab app turns mobiles nationwide into a virtual supercomputer network to crunch complex genetic data speeding up the search for a cure – all while you sleep.

While the Vodafone DreamLab app can be used by every Kiwi with a smartphone, for Vodafone mobile customers there’s the added reassurance of knowing that you won’t use up any of the data on your plan or be charged in any way to join in on the New Zealand network. The app also works on WiFi.

For Vodafone CEO Russell Stanners it’s all about connecting for good through the power of the Vodafone network.

“Finding a cure is so important for all of us and the beauty of the Vodafone DreamLab app is that the more Kiwis who download and use it, the faster it crunches data, and the closer researchers can get to find a cure.

“To kick it off, we’re giving our staff an extra hour of cancer-solving sleep by starting work one hour later next Friday (18 May). We’re calling it National Sleep-in Day, and we’d love as many businesses and individual Kiwis to join us as possible either starting late that day or encouraging teams to download the app,” Russell said.

Vodafone Foundation Manager Lani Evans said it’s been heartening to see high-profile support pour in for the Vodafone DreamLab app.

“We’ve had Kiwi companies’ large and small sign up to support the Vodafone DreamLab app, and we are also absolutely thrilled to have Kiwi legend Anika Moa, complete with fluffy slippers, throw her weight behind our National Sleep-in Day. DreamLab was developed in partnership with the Australian-based Garvan Institute of Medical Research, which has pioneered world-class cancer genomics research.

“Based on our tests adding just 33 new devices to the Vodafone DreamLab app enables the analysis of the same amount of data as quickly as a single CPU core of a typical research organisation’s in-house supercomputer,” Lani said.

Garvan Institute Cancer Researcher Dr Samantha Oakes said it’s only through medical research that cancer can be solved.

“Medical research generates a vast amount of complex data and information that must be analysed in order to make the next discovery. Smartphones now offer a tremendous opportunity to speed up research and unravel more of the cancer puzzle,” Dr Oakes said.

For more on how the Vodafone DreamLab app works, how to download it, and what you can do to say goodnight to cancer, head to www.vodafone.co.nz/dreamlab/ now.

Latest News
14 May 2020
Vodafone Aotearoa has kicked off an online Haka challenge, in partnership with The Haka Experience, to show new ways of spreading the message of aroha, unity and resilience virtually during the COVID-19 pandemic.
8 May 2020
Encouraging Kiwis to continue to stay at home, Vodafone NZ, video platform Play Stuff and Auckland-based esports provider LetsPlay.Live are today launching a new gaming event, the ‘Bubble Royale’. The two day tournament will see NZ celebrities including rugby greats Luke Jacobson and Josh Ioane, the Vodafone Warriors, surfing star Elliot Paerata-Reid, and top musicians like Ji Fraser from SIX60 and Hip Hop star Kings go head to head against fan players in rounds of global phenomenon Fortnite.
6 April 2020
By Lani Evans, Vodafone Foundation and Sustainability Manager

Network Status

Mobile ›
Excellent Very Good Good Fair Low No Connection
Landline & Broadband ›
Excellent Very Good Good Fair Low No Connection

Internet Explorer Not Supported

Please note that we do not support Internet Explorer. For optimal browsing we recommend Chrome, Safari, or Firefox.